Lymphoproliferative Disease

References

• Carli, P.M. and Maynadie, M. (2002) "Epidemiology and etiology of non-Hodgkin's lymphoma", Rev. Prat. 52(90), 945–950.
   PubMedGoogle Scholar
• Peh, S.C. and Poppema, S. (2001) "Lymphoma: an introduc-tion into historical background, classification schemes, etiology, geographical variation and epidemiological trend", Malays J. Pathol. 23(2), 49–63.
   PubMedGoogle Scholar
• Schiffer, CA. (2001) "Treatment of high grade lymphoid malignancies", Semin. Hematol. 38(4 Suppl. 10), 22–26.
   PubMed Web of Science ®Google Scholar
• Pagnano, K.B.B., Vassallo, J., Lorand-Metze, I., Costa, EE and Saad, S.T.O. (2001) "P53, Mdm2 and c-Myc over expression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas", Am. J. Hematol. 67, 84–92.
   PubMed Web of Science ®Google Scholar
• Hernandez, L., Hernandez, S., Bea, S., Pinyol, M., Ferrer, A., Bosch, F., Nadal, A., Fernandez, Pi., Palacin, A., Monsterraal, E.C.C. and Campo, E. (1999) "c-Myc mRNA expression and genomic alterations in mantle cell lymphoma and other nodal non-Hodgkin's lymphomas", Leukemia 13(12), 2087–2093.
   PubMed Web of Science ®Google Scholar
• Sanchez, E., Chacon, I., Plaza, M.M., Munoz, M., Cruz, MA., Martinez, B., Lopez, I., Martinez-Montero, J.C., Orradre, J.L., Saez, Al., Garcia, J.F. and Pins, M.A. (1998) "Clinical outcome in diffuse large B cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins", J. Clin. Oncol. 16, 1931–1939.
   PubMed Web of Science ®Google Scholar
• Hoffman, B., Amanullah, A., Shafarenko, M. and Liebermarm, D.A. (2002) "The proto-oncogene c-Myc in hematopoietic development and leukemogenesis", Oncogene 13, 21(21), 3414–3421.
   Google Scholar
• Schuldiner, O., Shor, S. and Benvenisty, N. (2002) "A computerized database—scan to identify c-Myc target", Gene 292(1–2), 91–99, Jun 12.
   PubMed Web of Science ®Google Scholar
• Tsuneoka, M., Koda, Y, Soejima, M., Teye, K. and Kimura, H. (2002) "A novel myc target gene, mina 53, that is involved in cell proliferation", J. Biol. Chem. 277(38), 35450–35459.
   PubMed Web of Science ®Google Scholar
• Lutz, W., Leon, J. and Eilers, M. (2002) "Contributions of Myc to tumorigenesis", Biochem. Biophys. Acta 14, 1602(1), 61–71.
   Google Scholar
• Zhang, A., Ohshima, K., Sato, K., Kanda, M., Suzumyla, K., Kawasaki, C. and Kikuchi, M. (1999) "Prognostic clinico-pathologic factors, including immunologic expression in diffuse large B cell lymphomas", Pathol. Int. 49, 1043–1052.
   PubMed Web of Science ®Google Scholar
• Kramer, M.H.H., Hermans, J., Wijburg, E., Philippo, K., Geelen, E., Van Krieken, J.H.J.M., de Jong, D., Maarense, E., Schuuring, E. and Kluin, EM. (1998) "Clinical relevance of Bc12,Bc16 and c-Myc rearrangements in diffuse large B cell lymphoma", Blood 92(9), 3152–3162.
   PubMed Web of Science ®Google Scholar
• Chung, C.C., Liu, Y, Ronald, P. and Perkins, S.L. (2000) "Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B cell lymphomas", Am. J. Clin. Pathol. 113(4), 512–518.
   PubMed Web of Science ®Google Scholar
• Ikeda, T., Sato, K., Yamashita, T., Kanai, Y., Kuwada, N., Matsumura, N., Nakamura, Y, Kimura, E and Motoyoshi, K. (2001) "Burkitt's acute lymphoblastic leukemia transforma-tion after myelodysplastic syndrome", Br. J. Hematol. 115(1), 69–71.
   PubMed Web of Science ®Google Scholar
• Nakamura, N., Nakamine, H., Tamaru, J., Yoshino, T., Nakamura, S. and Ohshima, K. (2002) "The distinction between Burkitt's lymphoma and diffuse large B cell lymphoma with c-Myc rearrangement", Mod. Path. 15(7), 771— 776.
   PubMed Web of Science ®Google Scholar
• Lssos, IS., Alizadeh, A.A., Diehn, M., Warnke, R., Thorstenson, Y, Oefner, P., Brown, EO., Botstein, D. and Levy, R. (2002) "Transformation of follicular lymphoma to diffuse large cell lymphoma: Alternative patterns with increased or decreased expression of c-Myc and its regulated gene", Proc. Natl Acad. Sci. USA. 99(13), 8886–8891.
   PubMed Web of Science ®Google Scholar
• Hernandez, S., Hernandez, L., Bea, S., Pinyol, M., Nayach, I., Bellosillo, B., Nadal, A., Ferrer, A., Fernandez, P.L., Montserrat, E., Cardesa, A. and Campo, E. (2000) "Cdc25A and the splicing variant Cdc25B2, but not Cdc25B1, -B3 or-C, are over expressed in aggressive human non-Hodgkin's lymphomas", Int. J. Cancer 89(2), 148–152.
   PubMed Web of Science ®Google Scholar
• Korkolopoulou, P., Patsouris, E., Pangalis, G., Tsenga, A., Elemenoglou, J., Thomas, E., Spandidos, D. and Kittas, C. (1993) "A comparative assessment of proliferating cell nuclear antigen c-Myc p62, and nuclear organizer region staining in non-Hodgkin's lymphomas: A Histochemical and immunohistochemical; Study of 200 cases", Hum. Pathol. 24(4), 371–377.
   PubMed Web of Science ®Google Scholar
• Mitani, S., Sugawara, I., Shiku, H. and Mori, S. (1988) "Expression of c-Myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques", Cancer 62, 2085–2093.
   PubMed Web of Science ®Google Scholar
• Vitolo, U., Gaidano, G., Botto, B., Volpe, G., Audisio, E., Bertini, M., Calvi, R., Freilone, R., Novero, D., Orsucci, L., Pastore, C., Capello, D., Parvis, G., Sacco, C., Zagonel, V., Carbone, A., Mazza, U., Palestro, G., Saglio, G. and Resegotti, L. (1998) "Rearrangement of bd-6, bc1-2, c-Myc and 6q deletion in B diffuse lagre cell lymphoma: clinical relevance in 71 patients", Ann. Oncol. 9(1), 55–61.
   PubMed Web of Science ®Google Scholar
• Akasaka, T., Akaska, H., Veda, C., Yonetani, N. and Maesako, Y. (2000) "Molecular and clinical features of NHL, DLCL of B cell type associated with c-Myc/Ig heavy chain fusion gene", J. Clin. Oncol. 181(3), 510–518.
   Google Scholar
• Doria, G. and Frasca, D. (1997) "Genes, immunity and senescence: looking for a link", Immunol. Rev. 160, 159–170.
   PubMed Web of Science ®Google Scholar
• Kittas, C., Korkolopoulou, P., Pangalis, G., Bonssiotis, V.A., Tsenga, A. and Spandidos, D. (1990) "Expression of c-Myc P62 protein in non-Hodgkin's lymphomas", Leuk. Lymphoma 1, 241–247.
   PubMedGoogle Scholar
• Korkolopoulou, P., Oates, J., Kittas, C. and Crocker, J. (1994) "P53, cmyc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphoma", J. Clin. Pathol. 47(1), 9–14.
   PubMed Web of Science ®Google Scholar
• Cangi, M.G., Cukor, B., Soungcang, P, Signoretti, S., Moreira, G., Ranashinge, M., Cady, B., Pagano, M. and Loda, M. (2002) "Role of the Cdc25A phosphatase in human breast cancer", J. Clin. Invest. 106(6), 753–761.
   Web of Science ®Google Scholar
• Main, M., Hsu, B., Stephens, L.C., Brisbay, S. and Mc Donnell, T.J. (1995) "The functional basis of c-Myc and bc1-2 complementation during multistep lymphogenesis in vivo", Exp. Cell. Res. 217(2), 240–247.
   PubMed Web of Science ®Google Scholar
• Lovec, H., Grzeschiczek, A., Kowalski, M.B. and Moroy, T. (1994) "Cyclin D1 /bc11 cooperates with Myc genes in the generation of B cell lymphoma in transgenic mice", EMBO J. 13(15), 3487–3495.
   PubMed Web of Science ®Google Scholar
• Hernandez, L., Henandez, S., Bea, S., Pinyol, M., Ferrer, A., Bosch, E, Nadal, A., Fernondez,Mack', A., Monsterrdl, E.C. and Camgo, O.E. (1999) "c-Myc m RNA expression and genomic alterations in mantle cell lymphoma and other nodal non Hodgkin's lymphoma", Leukemia 13, 2087–2093.
   PubMed Web of Science ®Google Scholar
• Arcinas, M., Heckman, C.A., Mehew, J.W. and Boxer, L.M. (2001) "Molecular mechanisms of transcriptional control of Bc12 and c-Myc in follicular and transformed lymphoma", Cancer Res. 61, 5202–5206.
   PubMed Web of Science ®Google Scholar
• Yano, T., van Krieken, J.H., Magrath, IT., Longo, DJ., Jaffe, E.S. and Raffeld, M. (1992) "Histogenetic correlations between subcategories of small non cleaved cell lympho-mas", Blood 79(5), 1282–1290.
   PubMed Web of Science ®Google Scholar
• Benbouker, L., Valat, C., Linassier, C., Cartron, G., Delain, M., Bout, M., Fetissof, E, Lefranq, T., Lamagnere, J.P. and Colombat, P. (2000) "A new serologic index for low grade non Hodgkin's lymphoma based on initial CA 125 and LDH serum levels", Ann. Oncol. 11(11), 1485–1491.
   PubMed Web of Science ®Google Scholar
• Kondo, E., Og-ura, M., Kagami, Y., Taji, H., Hiura, K., Takeuchi, T., Maeda, S., Asakura, S., Suzuki, R., Nakamura, S. and Morishima, Y. (2001) "Assessement of prognostic factors in follicular lymphoma patients", Int. J. Hematol. 73(3), 363–368.
   PubMed Web of Science ®Google Scholar
• Pajic, A., Spitkovsky, D., Christoph, B., Kempkes, B., Schuhmacher, M., Staege, US., Brielmeier, M., Ellwart, J., Kohlhuber, F., Bornkamm, G.W., Polack, A. and Eick, D. (2000) "Cell cycle activation by c-Myc in a Burkitt's lymphoma model cell line", Int. J. Cancer 87(6), 787–793.
   PubMed Web of Science ®Google Scholar
• Reiser, M., Josting, A., Soltani, M., Staib, P., Salazberger, B., Dieh, V. and Engert, A. (2002) "T-cell NHL in adults: clinicopathological Characteristics, response to treatment and prognostic factors", Leuk. Lymphoma 43(4), 805–811.
   PubMed Web of Science ®Google Scholar
• Penz, M.Z., Fiebiger, W.C., Valencak, J.B., Osterreicher, C., Ba-Salamah, A., Formanek, M., Brodowic, T., Chott, A. and Raderer, M. (2001) "B2 microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa associated lymphoid tissue(MALT)-type: a retrospective analysis", Anticancer Res.(4B), 3049–3052.
   Google Scholar
• Suki, S., Swan, Jr, E, Tucker, S., Fritsche, HA., Redman, JR., Rodriguez, MA., McLaughlin, P., Romaguera, J., Hagemeister, F.B., Velasqez, W.S., et al. (1995) "Risk classification for large cell lymphoma using lactate dehydro-genase, beta 2 microglobulin, and thymidine kinase", Leuk. Lymphoma 18(1–2), 87–92.
   Web of Science ®Google Scholar
• Kawasaki, C., Ohshim, K., Suzumiya, J., Kanda, M., Tsuchiya, T., Tamura, K. and Kikuchi, M. (2001) "Rearrangements of bd-1,bc1-2,bc1-6 and c-Myc in diffuse large B-cell lympho-mas", Leuk. Lymphoma 42(5), 1099–1106.
   PubMed Web of Science ®Google Scholar
• Henriksson, M. and Luscher, B. (1996) "Proteins of the c-Myc network:Essential regulators of cell growth and differen-tiation", Adv. Cancer Res. 68(82), 109–115.
   PubMedGoogle Scholar
• Baudino, TA., McKay, C., Pendeville-Samain, H., Nilsson, J.A., Maclean, K.H., White, EL., Davis, AC., Ihle, J.N. and Cleveland, J.L. (2002) "c-Myc is essential for vasculogenesis and angiogenesis during development and tumor pro-gression", Genes Dev. 16(19), 2530–2543.
   PubMed Web of Science ®Google Scholar
• Fest, T., Mougey, V, Dalstein, V, Hageerty, M., Milette, D., Silva, S. and Mai, S. (2002) "c-Myc over expression in Ba/F3 cells simultaneously elicits genomic instability and apopto-sis", Oncogene 21(19), 2981–2990.
   PubMed Web of Science ®Google Scholar